Evidence map›Paper›PMID 31510823›Full record

ArticleJournal of the American Heart Association2019

Renal Resistive Index Is Associated With Inactive Matrix Gla (γ-Carboxyglutamate) Protein in an Adult Population-Based Study.

David A Jaques, Edward Pivin, Menno Pruijm, Daniel Ackermann, Idris Guessous, Georg Ehret, Fang-Fei Wei, Jan A Staessen, Antoinette Pechère-Bertschi, Cees Vermeer and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

David A JaquesDivision of Nephrology Geneva University Hospitals Geneva Switzerland.
Edward PivinDivision of Chronic Disease University Institute of Social and Preventive Medicine Lausanne University Hospital Lausanne Switzerland.
Menno PruijmDivision of Nephrology and Hypertension Lausanne University Hospital and University of Lausanne Lausanne Switzerland.
Daniel AckermannUniversity Clinic for Nephrology, Hypertension and Clinical Pharmacology Bern University Hospital Bern Switzerland.
Idris GuessousDivision of Primary Care Medicine Department of Primary Care Medicine Geneva University Hospitals Geneva Switzerland.
Georg EhretDivision of Cardiology Geneva University Hospitals Geneva Switzerland.
Fang-Fei WeiStudies Coordinating Centre Research Unit of Hypertension and Cardiovascular Epidemiology KU Leuven Department of Cardiovascular Sciences University of Leuven Belgium.
Jan A StaessenStudies Coordinating Centre Research Unit of Hypertension and Cardiovascular Epidemiology KU Leuven Department of Cardiovascular Sciences University of Leuven Belgium.
Antoinette Pechère-BertschiDivision of Hypertension Geneva University Hospitals Geneva Switzerland.
Cees VermeerR&D Group VitaK Maastricht University Maastricht The Netherlands.
Bruno VogtUniversity Clinic for Nephrology, Hypertension and Clinical Pharmacology Bern University Hospital Bern Switzerland.
Michel BurnierDivision of Nephrology and Hypertension Lausanne University Hospital and University of Lausanne Lausanne Switzerland.
Pierre-Yves MartinDivision of Nephrology Geneva University Hospitals Geneva Switzerland.
Murielle BochudDivision of Chronic Disease University Institute of Social and Preventive Medicine Lausanne University Hospital Lausanne Switzerland.
Belen PonteDivision of Nephrology Geneva University Hospitals Geneva Switzerland.
University Hospital of Geneva · CHUniversity of Lausanne · CHInstitute of Social and Preventive Medicine · CHKU Leuven · BEUniversity Hospital of Bern · CHMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Increased renal resistive index (RRI) has been associated with target organ damage as well as renal and cardiovascular outcomes. Matrix Gla (γ-carboxyglutamate) protein (MGP) is a strong inhibitor of soft tissue calcification. Its inactive form (dephospho-uncarboxylated MGP [dp-ucMGP]) has been associated with vascular stiffness, cardiovascular outcomes, and mortality. In this study, we hypothesized that high levels of dp-ucMGP were associated with increased RRI. Methods and Results We recruited participants via a multicenter family-based cross-sectional study in Switzerland. Levels of dp-ucMGP were measured in plasma by sandwich ELISA. RRI was measured by Doppler ultrasound in 3 segmental arteries in both kidneys. We used mixed regression models to assess the relationship between dp-ucMGP and RRI. We adjusted for common determinants of RRI as well as renal function and cardiovascular risk factors. We included 1006 participants in our analyses: 526 women and 480 men. Mean values were 0.44±0.20 nmol/L for dp-ucMGP and 64±5% for RRI. After multivariable adjustment, dp-ucMGP was positively associated with RRI (

Indexed as

Blood Flow VelocityVascular StiffnessAdultAgedCalcium-Binding ProteinsDiabetes MellitusExtracellular Matrix ProteinsFemaleHumansHypertensionMaleMatrix Gla ProteinMiddle AgedPulse Wave AnalysisRenal ArterySex FactorsCalcium-Binding ProteinsExtracellular Matrix ProteinsMatrix Gla Proteinatherosclerosismatrix Gla (γ‐carboxyglutamate) proteinpulse pressurepulse wave velocityrenal physiologyrenal resistive indexvascular stiffness

Identifiers

PMID31510823
PMCPMC6818003
OpenAlexW2972948231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.